TickerGuard
Buy Day today: Neutral (60) Mixed market breadth · no major macro event
OBX

Obsidian Therapeutics, Inc.

Healthcare · Biotechnology

13.60$ +2.0% vs. previous close Closing price · As of: Oct 2, 2026

Statements

Cash Flow

Obsidian Therapeutics, Inc. (OBX) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q1 26), "Operating Cash Flow" came in at -22 million USD. Tick rows to compare them in a chart.

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Cash Flow OBX
Line item Q4 22 Q1 23 Q2 23 Q1 25 Q1 26
– – – -24 -22
– – – 0.4 0.3
– – – 2.1 1.5
– – – -1.0 -3.9
0.0 0.0 0.0 0.1 0.0
– – – 0.0 0.0
– – – -11 -14
– – – -24 -22

Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?